Volume 11, Issue 4, Pages (October 2006)

Slides:



Advertisements
Similar presentations
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Advertisements

Volume 6, Issue 1, Pages (July 2000)
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
Volume 11, Issue 2, Pages (April 2015)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
M. Wang, H. Jin, D. Tang, S. Huang, M.J. Zuscik, D. Chen 
Volume 23, Issue 6, Pages (December 2012)
M. Wang, H. Jin, D. Tang, S. Huang, M.J. Zuscik, D. Chen 
Volume 9, Issue 20, Pages S1-S2 (October 1999)
Volume 15, Issue 2, Pages (February 2009)
Volume 8, Issue 6, Pages (December 2005)
Volume 10, Issue 4, Pages (October 2009)
Volume 22, Issue 5, Pages (May 2012)
Volume 11, Issue 6, Pages (December 2006)
Volume 137, Issue 3, Pages (September 2009)
Ectodermal Smad4 and p38 MAPK Are Functionally Redundant in Mediating TGF- β/BMP Signaling during Tooth and Palate Development  Xun Xu, Jun Han, Yoshihiro.
Volume 18, Issue 3, Pages (April 2005)
Skin-Specific Deletion of Mis18α Impedes Proliferation and Stratification of Epidermal Keratinocytes  Koog Chan Park, Minkyoung Lee, Yoon Jeon, Raok Jeon,
Mark H Kaplan, Ulrike Schindler, Stephen T Smiley, Michael J Grusby 
Volume 7, Issue 6, Pages (June 2005)
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Volume 8, Issue 5, Pages (November 2010)
Volume 58, Issue 3, Pages (September 2000)
Volume 29, Issue 3, Pages (May 2014)
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
JNK2 Is a Positive Regulator of the cJun Transcription Factor
Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies  O.Jameel Shah,
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Role of p38 MAPK in UVB-Induced Inflammatory Responses in the Skin of SKH-1 Hairless Mice  Arianna L. Kim, Jeffrey M. Labasi, Yucui Zhu, Xiuwei Tang,
Volume 88, Issue 4, Pages (February 1997)
Volume 27, Issue 2, Pages (October 2013)
Volume 2, Issue 6, Pages (June 2002)
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 127, Issue 1, Pages (October 2006)
Halofuginone, an Inhibitor of Type-I Collagen Synthesis and Skin Sclerosis, Blocks Transforming-Growth-Factor-β-Mediated Smad3 Activation in Fibroblasts 
Volume 32, Issue 1, Pages (October 2008)
Volume 7, Issue 1, Pages (January 2008)
Volume 56, Issue 5, Pages (December 2014)
Volume 19, Issue 5, Pages (November 2003)
Volume 46, Issue 1, Pages (April 2012)
Hus1 Acts Upstream of Chk1 in a Mammalian DNA Damage Response Pathway
Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice  Jie Zhu, Simone Petersen, Lino Tessarollo,
Volume 50, Issue 2, Pages (April 2013)
Hydroxychloroquine Modulates Metabolic Activity and Proliferation and Induces Autophagic Cell Death of Human Dermal Fibroblasts  Bettina Ramser, Agatha.
Volume 27, Issue 2, Pages (July 2007)
Volume 8, Issue 6, Pages (December 2005)
Functional Redundancy of ERK1 and ERK2 MAP Kinases during Development
Volume 10, Issue 4, Pages (April 1999)
TAK1 Is Required for Dermal Wound Healing and Homeostasis
Volume 70, Issue 5, Pages (September 2006)
Volume 39, Issue 3, Pages (August 2010)
Yvonne Ng, Georg Ramm, Jamie A. Lopez, David E. James  Cell Metabolism 
Volume 32, Issue 1, Pages (October 2008)
Volume 10, Issue 5, Pages (May 2006)
Volume 16, Issue 4, Pages (April 2009)
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 14, Issue 1, Pages (January 2001)
Deon G. Uffort, Elizabeth A. Grimm, Julie A. Ellerhorst 
Volume 7, Issue 3, Pages (March 2005)
A CDK-Independent Function of Mammalian Cks1
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Differential Roles of WAVE1 and WAVE2 in Dorsal and Peripheral Ruffle Formation for Fibroblast Cell Migration  Shiro Suetsugu, Daisuke Yamazaki, Shusaku.
Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.
Effect of bevacizumab on the proliferation of A2780 cells.
Expression and induction of HER2 and HPSE in 231BMBC cells.
Volume 19, Issue 3, Pages (September 2010)
Volume 31, Issue 5, Pages (September 2008)
Presentation transcript:

Volume 11, Issue 4, Pages 583-589 (October 2006) Multiallelic Disruption of the rictor Gene in Mice Reveals that mTOR Complex 2 Is Essential for Fetal Growth and Viability  Chiyo Shiota, Jeong-Taek Woo, Jill Lindner, Kathy D. Shelton, Mark A. Magnuson  Developmental Cell  Volume 11, Issue 4, Pages 583-589 (October 2006) DOI: 10.1016/j.devcel.2006.08.013 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 rictor Gene Disruption Leads to Growth Arrest and Embryonic Lethality (A) Diagram of the recombinase-mediated gene conversion strategy and the structure of four different allelic variants of the rictor gene. The parental riclacZ+neo allele generated by gene targeting contains both a lacZ cassette fused to exon 3 and an intact exon 3. (B) Wild-type and riclacZ+neo/lacZ+neo embryos at E14.5. The riclacZ+neo/lacZ+neo embryo exhibits hydrops fetalis. (C) Real-time PCR analysis showing a small amount of expression of rictor in riclacZ+neo/lacZ+neo embryos. Results are means ± SD of samples in duplicate. The asterisk indicates that no signal was detected. (D) Level of rictor protein in wild-type (ric+/+), heterozygous (ric+/−), and homozygous (ric−/−) embryos at E10.5. Western blots were performed with an anti-rictor antibody. (E) Embryos that were homozygous for the rictor conditional allele (ricEx3cond/Ex3cond), heterozygous for the rictor null allele (ricEx3cond/lacZ), and homozygous for the rictor null allele (ricEx3del/lacZ) with β-gal staining at E9.5. (F) rictor conditional (ricEx3cond/Ex3cond) and null (ricEx3del/lacZ) embryos at E10.5. (G) Toluidine blue-stained resin sections from control (ricEx3cond/w) and rictor null (ricEx3del/Ex3del) embryos at E10.5. VZ, ventricular zone of the neuroepithelium; MZ, marginal zone of the neuroepithelium; M, mesenchymal cell; B, blood cell. The scale bars are 5 mm in (B), 1 mm in (E) and (F), and 10 μm in (G). Developmental Cell 2006 11, 583-589DOI: (10.1016/j.devcel.2006.08.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 rictor Disruption Causes Developmental Abnormalities in the Labyrinth Layer of the Placenta (A) Whole-mount β-gal staining of placenta from a ricEx3cond/lacZ embryo with maternal decidua (dec) (genotype of dam, ricEx3cond/Ex3del) at E9.5 demonstrating strong expression of the rictor gene in fetal placenta (asterisk) and yolk sac (arrows). (B and C) In situ hybridization for PL-1 on sections from (B) ricw/w and (C) riclacZ+neo/lacZ+neo placentas at E16.5. sp, spongiotrophoblast; lb, labyrinth layer. (D and E) Immunostaining for glucose transporter 1 (Glut1) on sections from (D) ricEx3cond/w and (E) ricEx3del/Ex3del placentas at E10.5. Glut1 staining marks the syncytiotrophoblast in the labyrinth layer. The border of the fetal placenta is shown by a dashed line. d, decidua; g, giant trophoblast layer; sp, spongiotrophoblast layer; ch, chorionic plate. (F and G) Hematoxylin and eosin staining of the labyrinth layer (lb) of (F) ricEx3cond/Ex3cond and (G) ricEx3del/lacZ placentas at E10.5. ch, chorionic plate; g, giant trophoblast; m, maternal blood cells; f, fetal blood cells (nucleated). The scale bars are 1 mm in (A) and 100 μm in (B)–(G). Developmental Cell 2006 11, 583-589DOI: (10.1016/j.devcel.2006.08.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 rictor Disruption Reduces Phosphorylation of Akt/PKB on Ser473 Total lysates were prepared from pools of rictor wild-type and conditional embryos as a control (ric+/+) or from rictor null (ric−/−) embryos at E9.75 and 10.5. Proteins indicated were detected by Western blotting. Developmental Cell 2006 11, 583-589DOI: (10.1016/j.devcel.2006.08.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 rictor-Deficient MEFs Show Reduced Growth Rate, Metabolic Activity, and Growth Factor Signaling (A) Phalloidin staining for F-actin in the control (ricEx3cond/w) and rictor null (ricEx3del/Ex3del) MEFs. The scale bar is 100 μm. (B) Cell proliferation assay. The control or rictor null MEFs were incubated with BrdU in the presence of indicated concentrations of serum and PDGF. BrdU incorporation was measured by ELISA assay. Data are represented as means ± SD of triplicate determinants. Similar results were obtained in three independent experiments. ∗∗p < 0.01. (C) XTT assay for metabolic activity of MEFs. The formation of formazan dye from XTT in the indicated number of control or rictor null cells was monitored by the absorbance. Data are represented as means ± SD of six determinations. Similar results were obtained in three independent experiments. ∗∗p < 0.01. (D and E) Phosphorylation of Akt/PKB and MAPK in the control or rictor null MEFs in response to growth factors. Cells were treated with (D) 50 ng/ml IGF-1 or (F) 20 ng/ml PDGF for the indicated times. The indicated phosphoproteins were detected by Western blotting. eIF4E was included as a protein loading control. (F) In vitro kinase assay. Akt/PKB was immunoprecipitated from lysates of control or rictor null cells with or without serum stimulation and was incubated with substrate GSK3α/β. Phosphorylated GSK3α/β was detected by Western blotting. Phosphorylation of Thr308 on Akt/PKB detected by Western blotting is also shown. In this experiment, nonphosphorylated Akt/PKB was also detected by crossreaction of the antibody; thus, it appears at a slightly lower position than the phosphorylated proteins. Developmental Cell 2006 11, 583-589DOI: (10.1016/j.devcel.2006.08.013) Copyright © 2006 Elsevier Inc. Terms and Conditions